Nick Cammack

3.1k total citations
42 papers, 2.2k citations indexed

About

Nick Cammack is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Nick Cammack has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 25 papers in Virology and 16 papers in Hepatology. Recurrent topics in Nick Cammack's work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (25 papers) and Hepatitis C virus research (16 papers). Nick Cammack is often cited by papers focused on HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (25 papers) and Hepatitis C virus research (16 papers). Nick Cammack collaborates with scholars based in United States, United Kingdom and Germany. Nick Cammack's co-authors include Isabel Nájera, Klaus Klumpp, Sonal Rajyaguru, Sophie Le Pogam, Julian Symons, Vincent Lévêque, Wen-Rong Jiang, Hyunsoon Kang, Matthew F. McCown and Samir Ali and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Virology.

In The Last Decade

Nick Cammack

42 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Cammack United States 28 1.4k 927 890 807 557 42 2.2k
Donald J. Graham United States 19 1.4k 1.0× 590 0.6× 1.2k 1.4× 563 0.7× 496 0.9× 31 2.0k
Isabel Nájera United States 36 1.7k 1.2× 2.1k 2.2× 642 0.7× 1.9k 2.4× 726 1.3× 86 3.5k
George Kukolj Canada 33 1.2k 0.8× 1.9k 2.0× 527 0.6× 1.4k 1.7× 744 1.3× 86 3.2k
Manuel Tsiang United States 29 870 0.6× 363 0.4× 689 0.8× 553 0.7× 845 1.5× 47 2.6k
Donald R. O’Boyle United States 25 722 0.5× 1.4k 1.5× 259 0.3× 1.8k 2.2× 341 0.6× 37 2.4k
Kai Lin United States 25 588 0.4× 1.0k 1.1× 200 0.2× 919 1.1× 579 1.0× 50 2.0k
R. Clayton United Kingdom 16 577 0.4× 493 0.5× 507 0.6× 429 0.5× 471 0.8× 32 1.4k
Zuzana Hostomska United States 14 694 0.5× 397 0.4× 490 0.6× 378 0.5× 1.0k 1.9× 16 1.8k
Magdeleine Hung United States 21 622 0.4× 315 0.3× 532 0.6× 520 0.6× 456 0.8× 38 1.4k
Rodney S. Russell Canada 28 419 0.3× 899 1.0× 715 0.8× 894 1.1× 1.1k 2.0× 68 2.4k

Countries citing papers authored by Nick Cammack

Since Specialization
Citations

This map shows the geographic impact of Nick Cammack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Cammack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Cammack more than expected).

Fields of papers citing papers by Nick Cammack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Cammack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Cammack. The network helps show where Nick Cammack may publish in the future.

Co-authorship network of co-authors of Nick Cammack

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Cammack. A scholar is included among the top collaborators of Nick Cammack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Cammack. Nick Cammack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pogam, Sophie Le, Hyunsoon Kang, Alan Kosaka, et al.. (2010). RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients. The Journal of Infectious Diseases. 202(10). 1510–1519. 43 indexed citations
2.
Jekle, Andreas, Erhard Kopetzki, Changhua Ji, et al.. (2009). CD4-BFFI: A novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency. Antiviral Research. 83(3). 257–266. 11 indexed citations
3.
Hang, Julie Q., Yanli Yang, Seth F. Harris, et al.. (2009). Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus. Journal of Biological Chemistry. 284(23). 15517–15529. 71 indexed citations
4.
Kopetzki, Erhard, Andreas Jekle, Changhua Ji, et al.. (2008). Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1. Virology Journal. 5(1). 56–56. 22 indexed citations
5.
Ji, Changhua, Erhard Kopetzki, Andreas Jekle, et al.. (2008). CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability. Journal of Biological Chemistry. 284(8). 5175–5185. 21 indexed citations
6.
McCown, Matthew F., Sonal Rajyaguru, Sophie Le Pogam, et al.. (2008). The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 52(5). 1604–1612. 132 indexed citations
7.
Ji, Changhua, Jun Zhang, Marianna Dioszegi, et al.. (2007). CCR5 Small-Molecule Antagonists and Monoclonal Antibodies Exert Potent Synergistic Antiviral Effects by Cobinding to the Receptor. Molecular Pharmacology. 72(1). 18–28. 42 indexed citations
8.
Zhang, Jun, Marianna Dioszegi, Rama K. Kondru, et al.. (2007). The Second Extracellular Loop of CCR5 Contains the Dominant Epitopes for Highly Potent Anti-Human Immunodeficiency Virus Monoclonal Antibodies. Antimicrobial Agents and Chemotherapy. 51(4). 1386–1397. 20 indexed citations
9.
Pogam, Sophie Le, Wen-Rong Jiang, Vincent Lévêque, et al.. (2006). In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance. Virology. 351(2). 349–359. 101 indexed citations
10.
Ji, Changhua, Jun Zhang, Nick Cammack, & Surya Sankuratri. (2006). Development of a Novel Dual CCR5-Dependent and CXCR4-Dependent Cell-Cell Fusion Assay System with Inducible gp160 Expression. SLAS DISCOVERY. 11(1). 65–74. 23 indexed citations
11.
Hang, Julie Q., Yu Li, Yanli Yang, et al.. (2006). Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs). Biochemical and Biophysical Research Communications. 352(2). 341–350. 42 indexed citations
12.
Ma, Han, Vincent Lévêque, Anniek De Witte, et al.. (2004). Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors. Virology. 332(1). 8–15. 52 indexed citations
13.
Greenberg, Michael, Nick Cammack, Miklos Salgo, & Lynn Smiley. (2004). HIV fusion and its inhibition in antiretroviral therapy. Reviews in Medical Virology. 14(5). 321–337. 56 indexed citations
14.
Hang, Julie Q., Surendran Rajendran, Yanli Yang, et al.. (2004). Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides. Biochemical and Biophysical Research Communications. 317(2). 321–329. 42 indexed citations
15.
Cammack, Nick. (2001). The potential for HIV fusion inhibition. Current Opinion in Infectious Diseases. 14(1). 13–16. 13 indexed citations
16.
Craig, Charles, Esther Race, Lynne Whittaker, et al.. (1998). HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. AIDS. 12(13). 1611–1618. 52 indexed citations
17.
18.
Mansour, Tarek S., Haolun Jin, Wei Wang, et al.. (1995). Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues. Nucleosides and Nucleotides. 14(3-5). 627–635. 18 indexed citations
19.
Ingrand, Didier, Jonathan Weber, Charles A. Boucher, et al.. (1995). Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients. AIDS. 9(12). 1323–1330. 28 indexed citations
20.
Mansour, Tarek S., Haolun Jin, Wei Wang, et al.. (1995). Anti-Human Immunodeficiency Virus and Anti-Hepatitis-B Virus Activities and Toxicities of the Enantiomers of 2'-Deoxy-3'-oxa-4'-thiocytidine and Their 5-Fluoro Analogs in Vitro. Journal of Medicinal Chemistry. 38(1). 1–4. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald J. Graham Breakdown of academic impact, for papers by Isabel Nájera Breakdown of academic impact, for papers by George Kukolj Breakdown of academic impact, for papers by Manuel Tsiang Breakdown of academic impact, for papers by Donald R. O’Boyle Breakdown of academic impact, for papers by Kai Lin Breakdown of academic impact, for papers by R. Clayton Breakdown of academic impact, for papers by Zuzana Hostomska Breakdown of academic impact, for papers by Magdeleine Hung Breakdown of academic impact, for papers by Rodney S. Russell
Rankless by CCL
2026